期刊文献+

气相色谱—电子捕获法测定血中美托洛尔浓度 被引量:4

DETERMINATION. OF METOPROLOL IN PLASMA BY GAS CHROMATOGRAPHY AND ELECTRON-CAPTURE DETECTION
下载PDF
导出
摘要 本文用GC-ECD法测定血中美托洛尔浓度。美托洛尔及内标烯丙洛尔在四氢呋呋喃化下,能迅速、定量地转化为双-七氟丁酰化衍生物,经3% SE-30玻璃填充柱分离及ECD检测。本法线性范围10~1500 ng/ml(r=0.9993),美托洛尔的平均回收率97.30%,日内及日间差的变异系数分别小于7%租8%。本法已用于美托洛尔控释剂型的生物利用度及药代动力学研究,以及临床血药浓度监测。 A method is described to determine metoprolol in plasma by GC-ECD. Metoprolol and alprenolol (internal standard) reacted rapidly with heptafluorobutyric anhydride under the catalysis of tetrahydrofuran (THF)after being extracted from plasma with cyclohexane. The derivatives produced quantitatively were identified by GC-MSD to be diheptafluorobutyl metoprolol and diheptafluorobutyl alpredolol which were then separated and detected by 3% SE-30 packed glass column (2m×3mm)equipped with ECD. The detection limit was 1 ng/ml and the linearrangewas 10~1500 ng/ml (r=0.9993).Average recovery from spiked plasma was 97.30%. The coefficient of variation of day-to-day and within-day were less then 8% and 7%, respectively. The method has been applied to investigate the Pharmacokinetics and bioavailability of metoprolol and also applied to clinical monitoting of metoprolol levels in patients.
出处 《药学学报》 CAS CSCD 北大核心 1990年第6期457-461,共5页 Acta Pharmaceutica Sinica
关键词 美托洛尔 GC-ECD法 Metoprolol GC- ECD Diheptafluorobutyric derivatives
  • 相关文献

同被引文献23

  • 1郑俊民,徐晖,丁平田.贴剂的黏贴原理和黏贴性试验[J].中医外治杂志,2005,14(4):3-5. 被引量:10
  • 2王文刚,恽榴红,王睿,周筱青.高效液相色谱法同时测定经皮渗透液中美托洛尔和非洛地平的含量[J].中国药学杂志,2006,41(2):143-146. 被引量:10
  • 3HARIA M, PLOSKER G L, MARKHAM A. Felodipine/Metoprolol : a review of the fixed dose controlled release formulation in the management of essential hypertention [ J ]. Drags, 2000,59 ( 1 ) : 141-157.
  • 4DAHLOF B,JONSSON L,BORGHOLST O,et al. Improved antihypertensive efficiency of the felodipine-metoprolol extended-release tablet compared with each drug alone [ J ]. Blood Pressure, 1993,2( Suppl. 1 )37-45.
  • 5FRISHMAN W H, HAINER J W, SUQQ J. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT) [J]. Am J Hypertens,2006.19(4) :388-395.
  • 6TODD P A, FAULDS D, FELODIPINE. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders [ J ]. Drugs, 1992,44 ( 8 ) :251-277.
  • 7PLOSKER G L, CLISSOLD S P. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties,and therapeutic use in hypertension and ischaemic heart disease [ J ]. Drugs, 1992,43 ( 3 ) :382-414.
  • 8KIM J,SHIN S C. Controlled release of atenolol from the ethylenevinyl acetate matrix[J]. Int J Pharm,2004,273(1-2) :23-27.
  • 9KENDALL M J. Approaches to meeting the criteria for fixed dose antihypertensive combinations[ J ]. Drugs, 1995,50(3 ) :454-464.
  • 10ABERG J, ABRAHAMSSON B, GRIND M. Bioequivalence,pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers[J]. Eur J Clin Pharmacol, 1997,52(6) :471-477.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部